Skip to content

ASCOLABO

Active
Private limited companyfounded 200916 yrs activeKattestraat 19, 9300 Aalst, BelgiumKBO/BCE: BE 0819.241.214
Summary

ASCOLABO has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.2m and a net result of €241,033. Equity is growing by ~15.1% per year across the filed fiscal years. Its solvency ranks better than 56% of 18230 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisWatch ReportCompare
ASCOLABOActiveChecked score 82/100
Risk analysis ReportCompare

Overview

What they do
Medical imaging and medical laboratories
NACE 86910NACE 86901
1 site
How big
€1.8mtotal assets 2025
Equity
€1.2m
Profit
€241,033
Turnover not published (abridged schema)
Financially healthy?
82 Excellent Checked score 2025
Bankruptcy chance 12 m
0.1%
Who decides
Board
3 members
Accounts 18 d early1 of 3 deeds read
Why 82+ Lower-failure-rate sector+ Annual accounts: healthy financial profile+ Long track recordLatest accounts filed on timeShow the evidence

Checked score

Score 2025
82 / 100
Excellent
Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability86▲+5
Solvency95=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €100,000 at 30 days acceptable
Liquidity short (current ratio 0.52 against 1.07 in 2024; short-term debt: 29.7% and cash: 2.6% of total assets), and 30% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
70%
Return on assets
13.7%
Age of the figures
15 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 16 years 0 20 y
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 13-01-2026, 18 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
18 d early
2024
49 d early
2023
8 d early
2022
1 d early
2021
49 d early
2020
10 d late
2019
18 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 19 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today. Usually files around 13 January (5 of the last 5 filed years within 31 days of that day).
Companies Code · seven months
Position in the running window
30-06-2026 close02-10-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Appointments: Raepsaet Bruno, Leonard Raepsaet and…Power of attorney
  2. Annual accounts filedfiscal year 2025 · micro…
  3. Annual accounts filedfiscal year 2024 · micro…

Key points

  • Positive: Among the best 5% on equitysector median €129,633 · 18,233 companies €1.2m View
  • Positive: Result rose in 2025from €157,024 to €241,033 ▲ 53.5% View
  • New directorslatest change 21-09-2026 · 3 in office 3 joined View
  • Positive: 7 profitable years in a rowprofit 2025: €241,033 7 years View
  • Positive: Always filed on timeaccounts within the deadline every year 5 years View

By topic

Financials

Fiscal year
2025
Total assets
€1.8m
Profit
€241,033
Solvency
70.0%
Total assets▲ 13.2%
Net result
20192025
Go to Financials

Timeline

Events
14
Since
2017
Next accounts
by 31-01-2027
  1. 21-09-2026Appointments: Raepsaet Bruno, Leonard Raepsaet and Gaëlle…
  2. 13-01-2026Annual accounts filed
  3. 13-12-2024Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Medical imaging and medical laboratoriesNACE 86910
Founded
05-10-2009
Year ends
30-06
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure